BioNTech shares are down -8.0% to $102.49, extending a drop that began in premarket trading after the company said it would end its Phase 2 colorectal cancer trial. The announcement triggered a roughly -10% premarket decline, with the stock remaining sharply lower into the regular session.

PYPL is down roughly -14.1% to about $52.80 from Thursday's $61.47 close, with the move starting in after-hours trading and extending into Friday's regular session. The primary catalyst was a late-Thursday report that the Advent International–Stripe consortium abandoned its takeover pursuit after PayPal's board rejected its $60.50-per-share ($53 billion) bid as inadequate.

NIQ shares climbed roughly 63% over the 30-day window, closing at $19.07 on August 27, 2026, compared with $11.70 on July 28, 2026. The move was powered by a second-quarter 2026 earnings beat, a raised full-year outlook, and a credit-rating upgrade from S&P Global Ratings.

Aura Minerals shares climbed roughly 61.9% over 30 days, from $55.05 to $89.12, as gold and copper prices rallied sharply. The move followed strong second-quarter results, including record net income, an increased dividend, and a new share-buyback program.

Tempus AI shares rose roughly 70% over the last 30 days, climbing from about $41.55 on July 29, 2026, to $70.69 on August 27, 2026. The sharpest move came after a Phase 3 melanoma win from Merck and Moderna validated Tempus's pending $1.5 billion acquisition of Personalis.

AngloGold Ashanti (AU) rallied roughly 52% over the trailing 30 days, climbing from about $77.87 to $118.40 as gold prices surged. The move was amplified by a strong second-quarter earnings report, a new $2 billion share buyback, and a higher dividend.

PLTU, a leveraged single-stock exchange-traded fund (ETF) seeking 200% of the daily return of Palantir Technologies ( PLTR ), advanced roughly +109% over the trailing 30 days. The surge mirrored an approximately 50% gain in PLTR and was concentrated around Palantir's second-quarter earnings release in early August, when the underlying stock jumped about 29.5% in a single session.

The Breakwave Tanker Shipping ETF (BWET) gained roughly 79% over the last 30 days, rising from about $238 to $425 per share. The fund tracks crude-oil tanker freight futures rather than oil prices, shipping equities, or commodity spot rates.

CRWG, a 2x daily leveraged single-stock ETF (exchange-traded fund) on CoreWeave, rose roughly 77% over the trailing 30 days, while the underlying stock gained about 43%. The rebound was driven primarily by CoreWeave's latest quarterly results, which showed revenue up 112% year over year and a revenue backlog of more than $104 billion.

AAOX gained roughly 33% over the trailing 30 days, yet the advance masks an exceptionally volatile path and a quarter that remains deeply negative. The fund seeks 200% of the daily return of Applied Optoelectronics (AAOI) , a U.S. optical transceiver and laser manufacturer tied to the AI data-center buildout.

IRE gained roughly 21% over the last 30 days, climbing from about $8.09 to $9.81, rebounding off its late-July lows. The fund remains down approximately 73% over the trailing three months after a steep drawdown from its late-May levels near $36.

The central question is whether WidePoint Corporation (WYY) can climb from roughly $9.45 to a $15 price target, a gain of about 59%. Bullish factors include a record contract backlog, a multi-billion-dollar federal contract pipeline, and a shift toward higher-margin recurring services.

WYY rose +6.56% to $10.07 during regular trading, up from a $9.45 prior-session close. No fresh company-specific headline drove the move; the gain extends a rebound following the roughly -19% selloff after Aug 14 Q2 results.

PLDT Inc. (PHI) is trading down roughly -7.5% near $17.91 after closing at $19.37 on Aug. 26. The slide began premarket with a gap-down open near $18.51 and extended during regular-session trading.

LUCK traded down -7.27% during the regular session to $6.25 versus the prior close of $6.74. The move followed fiscal Q4 earnings released premarket, when shares initially fell roughly -11%.

BHVN shares fell -5.96% during regular trading to $15.94, pulling back after Wednesday's roughly +18% surge to $16.95. The decline reflects profit-taking following the prior session's rally on the up to $795 million SK Biopharmaceuticals licensing deal for its Kv7 epilepsy platform.

AI-driven demand is outpacing supply: Management indicates laser chip and transceiver demand exceeds capacity, with several product lines effectively sold out into the foreseeable future. New architecture cycles are opening: Near-packaged optics (NPO), co-packaged optics (CPO), and optical circuit switches (OCS) represent multi-billion-dollar addressable-market expansions still in early revenue stages.

REAX is trading down about -10.7% intraday during regular market hours, at roughly $23.75 versus a $26.59 prior close. The drop extends a post-merger pullback: shares spiked +18.5% on Aug 25 when the Real–RE/MAX combination debuted under REAX, then fell -6.5% on Aug 26.

HRL slid -8.86% to about $21.61, extending a premarket drop into the regular session after fiscal Q3 earnings. Q3 net sales missed consensus at $2.96B (down -2.4% YoY) versus roughly $3.03B expected, though adjusted EPS of $0.37 edged past the $0.35 estimate.

SCTX fell -9.87% to roughly $28.57 intraday versus its prior close of $31.70, with the decline occurring during regular market hours. The move extends a post-IPO unwind: shares ran from the $15.00 July 24 IPO price to a $39.60 high on Aug 20 before momentum reversed, including a -16% drop on Aug 25.